| Line Item | 2025-04-30 | Y/Y |
|---|---|---|
| Revenue | $222.3M | +10.6% |
| Cost of Revenue | $123.1M | +9.2% |
| Gross Profit | $99.3M | +12.3% |
| R&D Expense | $7.7M | +12.5% |
| SG&A Expense | $36.1M | -7.4% |
| Operating Income | -$154K | +98.8% |
| Pre-tax Income | $46K | +100.4% |
| Income Tax | $123K | +275.7% |
| Net Income | -$77K |
| Line Item | 2025-04-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $23.4M | -21.1% |
| Accounts Receivable | $39.3M | +52.9% |
| Inventory | $104.7M | +12.2% |
| Current Assets | $171.6M | +10.4% |
| Total Assets | $246.4M | +2.4% |
| Current Liabilities | $36.8M | +25.2% |
| Total Liabilities | $68.7M | +9.7% |
| Line Item | 2025-04-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.4M | -94.5% |
| Capital Expenditures | $3.2M | -33.9% |
| Investing Cash Flow | -$3.9M | +34.8% |
| Financing Cash Flow | -$3.7M | +65.3% |
| Free Cash Flow | -$1.8M | -109.1% |
| +99.4% |
| EPS (Basic) | -$0.01 | +98.9% |
| EPS (Diluted) | -$0.01 | +98.9% |
| Stockholders' Equity |
| $177.6M |
| -0.2% |